Abstract
Objective:
To review the literature on respiratory syncytial virus (RSV) as a cause of nosocomial infections (NI) on neonatal intensive care units (NICUs) and pediatric wards, and the effectiveness of various containment strategies.
Study Design:
We conducted a literature review to define characteristics of RSV NI, and to evaluate the relative effectiveness of various infection containment programs, including the use of palivizumab on the reported incidence of RSV NI on NICUs and pediatric wards.
Result:
Highly variable rates of RSV NI have not significantly changed since RSV was first identified. The evaluation of the effectiveness of containment strategies has relied on before/after study designs. Focus on rapid patient diagnosis, compliance of acceptable handwashing techniques and cohorting of patients and staff appears to form the backbone of most prevention and containment programs. When these or other measures have failed, the administration of palivizumab has been useful in halting the spread of RSV NI in children.
Conclusion:
RSV NI continues to be prevalent in the NICU despite adoption of infection control programs. Preventive measures should be employed to lower the risk of RSV NI and, if identified, appropriate containment strategies should be rapidly implemented.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Glezen WP, Taber LH, Frank AL, Kasel JA . Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140: 543–546.
Morris J, Blount RE, Savage RE . Recovery of cytopathogenic agent from chimpanzees with coryza. Proc Soc Exp Biol Med 1956; 92: 544–550.
Kapikian AZ, Bell JA, Mastrota FM, Johnson KM, Huebner RJ, Chanock RM . An outbreak of febrile illness and pneumonia associated with respiratory syncytial virus infection. Am J Hyg 1961; 74: 234–248.
Berkovich S . Acute respiratory illness in the premature nursery associated with respiratory syncytial virus infections. Pediatrics 1964; 34: 753–760.
Welliver RC, McLaughlin S . Unique epidemiology of nosocomial infection in a children's hospital. AJDC 1984; 138: 131–135.
Hall CB . Nosocomial respiratory syncytial virus infections: the ‘cold war’ has not ended. Clin Infect Dis 2000; 31: 590–596.
Macartney KK, Gorelick MH, Manning ML, Hodinka RL, Bell LM . Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control. Pediatrics 2000; 106: 520–526.
Berner R, Schwoerer F, Schumacher RF, Meder M, Forster J . Community and nosocomially acquired respiratory syncytial virus infection in a German paediatric hospital from 1988 to 1999. Eur J Pediatr 2001; 160: 541–547.
Cooper ER, Harnisch BA, Fujii AM, Brown E, Appugliese D . RSV in the NICU: risk factors, spectrum of disease, and the role of routine surveillance in prevention of nosocomial infections. Pediatr Res 2004; 55: 336A.
Doherty JA, Brookfield DS, Gray J, McEwan RA . Cohorting of infants with respiratory syncytial virus. J Hosp Infect 1998; 38: 203–206.
Gala CL, Hall CB, Schnabel KC, Pincus PH, Blossom P, Hildreth SW et al. The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection. JAMA 1986; 256: 2706–2708.
Gouyon JB, Pothier P, Guignier F, Portier H, Pujol HP, Kazmierczak A et al. Outbreak of respiratory syncytial virus in France. Eur J Clin Microbiol 1985; 4: 415–416.
Gustafson S . Investigation and control of an RSV cluster in a 26-bed level II/III nursery using electronic surveillance methods. Am J Infect Control 2005; 33: E125–E126.
Halasa NB, Williams JV, Wilson GJ, Walsh WF, Schaffner W, Wright PF . Medical and economic impact of a respiratory syncytial virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J 2005; 24: 1040–1044.
Hall CB, Douglas RG, Geiman JM, Messner MK . Nosocomial respiratory syncytial virus infections. N Engl J Med 1975; 293: 1343–1346.
Hall CB, Douglas RG . Nosocomial respiratory syncytial viral infections. Should gowns and masks be used? Am J Dis Child 1981; 135: 512–515.
Hall CB, Geiman JM, Douglas RG, Meagher MP . Control of nosocomial respiratory syncytial viral infections. Pediatrics 1978; 62: 728–731.
Hall CB, Kopelman AE, Douglas G, Geiman JM, Meagher MP . Neonatal respiratory syncytial virus infection. N Engl J Med 1979; 300: 393–396.
Isaacs D, Dickson H, O'Callaghan C, Sheaves R, Winter A, Moxon ER . Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Arch Dis Child 1991; 66: 227–231.
Karanfil LV, Conlon M, Lykens K, Masters CF, Forman M, Griffith ME et al. Reducing the rate of nosocomially transmitted respiratory syncytial virus. Am J Infect Control 1999; 27: 91–96.
Kilani RA . Respiratory syncytial virus (RSV) outbreak in the NICU: description of eight cases. J Trop Pediatr 2002; 48: 118–122.
Krasinski K, LaCouture R, Holtzman RS, Waithe E, Bonk S, Hanna B . Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission. J Pediatr 1990; 116: 894–898.
Langley JM, LeBlanc JC, Wang EEL, Law BJ, MacDonald NE, Mitchell I et al. Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: a pediatric investigators collaborative network on infections in Canada study. Pediatrics 1997; 100: 943–946.
Leclair JM, Freeman J, Sullivan BF, Crowley CM, Goldmann DA . Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med 1987; 317: 329–334.
Madge P, Paton JY, McColl JH, Mackie PLK . Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet 1992; 340: 1079–1083.
Simon A, Khurana K, Wilkesmann A, Muller A, Engelhart S, Exner M et al. Nosocomial respiratory syncytial virus infection: impact of prospective surveillance and targeted infection control. Int J Hyg Environ Health 2006; 209: 317–324.
Snydman DR, Greer C, Meissner HC, McIntosh K . Prevention of nosocomial transmission of respiratory syncytial virus in a newborn nursery. Infect Control Hosp Epidemiol 1988; 9: 105–108.
Thorburn K, Kerr S, Taylor N, van Saene HKF . RSV outbreak in a paediatric intensive care unit. J Hosp Infect 2004; 57: 194–201.
Vieira SE, Gilio AE, Miyao CR, Pahl MMC, Lotufo JPB, Hein N et al. Nosocomial respiratory syncytial virus infection in a pediatric ward. Infect Control Hosp Epidemiol 2003; 24: 468–469.
Wilson CW, Stevenson DK, Arvin AM . A concurrent epidemic of respiratory syncytial virus and echovirus 7 infections in an intensive care nursery. Pediatr Infect Dis J 1989; 8: 24–29.
Forster J, Schumacher RF . The clinical picture presented by premature neonates infected with the respiratory syncytial virus. Eur J Pediatr 1995; 154: 901–905.
Krasinski K . Severe respiratory syncytial virus infection: clinical features, nosocomial acquisition and outcome. Pediatr Infect Dis 1985; 4: 250–257.
Cox RA, Rao P, Brandon-Cox C . The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit. J Hosp Infect 2001; 48: 186–192.
Heerens AT, Marshall DD, Bose CL . Nosocomial respiratory syncytial virus: a threat in the modern neonatal intensive care unit. J Perinatol 2002; 22: 306–307.
Valenti WM, Clarke TA, Hall CB, Menegus MA, Shapiro DL . Concurrent outbreaks of rhinovirus and respiratory syncytial virus in an intensive care nursery: epidemiology and associated risk factors. J Pediatr 1982; 100: 722–726.
Okuonghae HO, Nwankwo MU, Okolo AA, Schuit KE . Nosocomial respiratory syncytial virus infection in a newborn nursery. Ann Trop Paediatr 1992; 12: 185–193.
Hall CB, Douglas RG . Modes of transmission of respiratory syncytial virus. J Pediatr 1981; 99: 100–103.
Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R . Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53 (RR-3): 1–36.
Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006; 118: 1774–1793.
Contreras PA, Sami IR, Darnell MER, Ottolini MG, Prince GA . Inactivation of a respiratory syncytial virus by generic hand dishwashing detergents and antibacterial hand soaps. Infect Control Hosp Epidemiol 1999; 20: 57–58.
Conly JM, Hill S, Ross J, Ross J, Lertzman J, Louie TJ . Handwashing practices in an intensive care unit: the effects of an educational program and its relationship to infection rates. Am J Infect Control 1989; 17: 330–339.
Goldman D, Larson E . Handwashing and nosocomial infections. N Engl J Med 1992; 327: 120–122.
Pittet D, Mourouga P, Perneger TV . Compliance with handwashing in a teaching hospital. Ann Intern Med 1999; 130: 126–130.
Sproat LJ, Inglis TJ . A multicenter survey of hand hygiene practice in intensive care units. J Hosp Infect 1994; 26: 137–148.
Kang JO, Kim CR . Nosocomial respiratory syncytial virus infection in a newborn nursery. J Korean Med Sci 1997; 12: 489–491.
Feltes TF, Cabalka AK, Miessner C, Piazza FM, Carlin DA, Top HF et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 2003; 143: 532–540.
Heerens AT, Marshall DD, Bose CL . Nosocomial respiratory syncytial virus: a threat in the modern neonatal intensive care unit. J Perinatol 2002; 22: 306–307.
Salcedo S, Vinzo J, Calico I, Campins M, Castillo F, Perapoch J et al. Administration of palivizumab (monoclonal antibodies against respiratory syncytial virus) during a nosocomial outbreak in a neonatal unit. Prenatal Neonatal Med 2000; 5 (Suppl 2): 180.
Abadesso C, Almeida HI, Virella D, Carreiro MH, Machado MC . Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit. J Hosp Infect 2004; 58: 38–41.
Mejias A, Chavez-Bueno S, Sanchez PJ . Respiratory syncytial virus prophylaxis. NeoReviews 2005; 6: e26–e30.
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflicts of Interest
Dr Groothuis, Dr Malinoski and Dr Eggleston have a proprietary interest in palivizumab, which is marketed by MedImmune Inc. Jay Bauman is a consultant to MedImmune and received financial support for data collection and analysis.
Rights and permissions
About this article
Cite this article
Groothuis, J., Bauman, J., Malinoski, F. et al. Strategies for prevention of RSV nosocomial infection. J Perinatol 28, 319–323 (2008). https://doi.org/10.1038/jp.2008.37
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2008.37
Keywords
This article is cited by
-
Effect of young sibling visitation on respiratory syncytial virus activity in a NICU
Journal of Perinatology (2015)
-
Healthcare workers as vectors of infectious diseases
European Journal of Clinical Microbiology & Infectious Diseases (2014)
-
Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants
Italian Journal of Pediatrics (2014)
-
Nosokomiale Infektionen in Kinderkliniken
Monatsschrift Kinderheilkunde (2013)
-
Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program
Bone Marrow Transplantation (2011)